Heim ME - Search Results

1

[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].

Steinke B, Kraft A, Reinold HM, Heim ME, Löffler B, Heidemann E, Richter C, Josten K, Bross K, Hofmann I, et al. Steinke B, et al. Among authors: heim me. Onkologie. 1989 Feb;12(1):19-21. doi: 10.1159/000216591. Onkologie. 1989. PMID: 2469999 Clinical Trial. German.

2

Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.

Steinke B, Bross K, Reinold HM, Heim ME, Schalk KP, Heidemann E, Josten K, Arnold H, Manegold C, Hoffman I, et al. Steinke B, et al. Among authors: heim me. Eur J Cancer. 1992;28(1):100-4. doi: 10.1016/0959-8049(92)90395-i. Eur J Cancer. 1992. PMID: 1373634 Clinical Trial.

3

Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.

Steinke B, Krüger HU, Kraft H, Heim ME, Günther E, Arnold H, Busch FW. Steinke B, et al. Among authors: heim me. Blut. 1988 Jun;56(6):269-71. doi: 10.1007/BF00320288. Blut. 1988. PMID: 2454690

4

[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy].

Heim ME, Fritze D, Ho AD, Mebes W, Abel U. Heim ME, et al. Onkologie. 1987 Dec;10(6):345-8. doi: 10.1159/000216441. Onkologie. 1987. PMID: 3327022 Clinical Trial. German.

5

[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].

Verhees S, Flechtner H, Queisser W, Heim ME, Fritz M, Trux F, Edler L. Verhees S, et al. Among authors: heim me. Onkologie. 1990 Feb;13(1):50-2. doi: 10.1159/000216720. Onkologie. 1990. PMID: 1692400 Clinical Trial. German.

6

Combined modality of radiation and chemotherapy for the treatment of gastric carcinoma. A review.

Queisser W, Heim ME. Queisser W, et al. Among authors: heim me. Onkologie. 1989 Aug;12(4):156-60. doi: 10.1159/000216630. Onkologie. 1989. PMID: 2677873 Review.

7

Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancer.

Heim ME, Schuster D, Flechtner H, Worst P, Queisser W. Heim ME, et al. Onkologie. 1989 Aug;12(4):161-3. doi: 10.1159/000216631. Onkologie. 1989. PMID: 2677874

8

5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".

Flechtner H, Queisser W, Heim ME, Henss H, Arnold H, Fritze D, Herrmann R, Fritsch H, Fritz M, Trux FA, et al. Flechtner H, et al. Among authors: heim me. Onkologie. 1987 Apr;10(2):67-71. doi: 10.1159/000216375. Onkologie. 1987. PMID: 3108738

9

Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'.

Queisser W, Flechtner H, Heim ME, Kabelitz K, Massner B, Edler L. Queisser W, et al. Among authors: heim me. Onkologie. 1989 Oct;12(5):202-6. doi: 10.1159/000216645. Onkologie. 1989. PMID: 2511533 Clinical Trial.

10

Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Heim ME, Siegmund R, Illiger HJ, Klee M, Rieche K, Berdel WE, Edler L. Heim ME, et al. Onkologie. 1990 Dec;13(6):444-7. doi: 10.1159/000216817. Onkologie. 1990. PMID: 2092281 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters